References
- Visscher PM, Wray NR, Zhang Q, et al. 10 Years of GWAS discovery: Biology, function, and translation. American J Hum Genet. 2017;101:5–22. doi:10.1016/j.ajhg.2017.06.005. PMID:28686856
- Tolbert VP, Coggins GE, Maris JM. Genetic susceptibility to neuroblastoma. Curr Opin Genet Dev. 2017;42:81–90. doi:10.1016/j.gde.2017.03.008.
- Wang K, Diskin SJ, Zhang H, et al. Integrative genomics identifies LMO1 as a neuroblastoma oncogene. Nature. 2011;469:216–220. doi:10.1038/nature09609. PMID:21124317
- Oldridge DA, Wood AC, Weichert-Leahey N, et al. Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism. Nature. 2015;528:418–421. PMID:26560027
- Zhu S, Zhang X, Weichert-Leahey N, et al. LMO1 Synergizes with MYCN to Promote Neuroblastoma initiation and metastasis. Cancer Cell. 2017;32:310–323 e5. doi:10.1016/j.ccell.2017.08.002.
- Delloye-Bourgeois C, Bertin L, Thoinet K, et al. Microenvironment-driven shift of cohesion/detachment balance within tumors induces a switch toward metastasis in Neuroblastoma. Cancer Cell. 2017;32:427–443 e8. doi:10.1016/j.ccell.2017.09.006. PMID:29017055
- Steeg PS. Targeting metastasis. Nat Rev Cancer. 2016;16:201–218. doi:10.1038/nrc.2016.25. PMID:27009393